Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-1996 | 12-1995 | 06-1995 | 03-1995 | |
| Sales | 297 | 5,030 | 23 | 9 |
| Gross Profit | 297 | 5,030 | 23 | 9 |
| Operating Income | 297 | 5,030 | 23 | 9 |
| Pre-tax Income | 297 | 5,030 | 23 | 9 |
| Net Income Continuous | -646 | 3,491 | -705 | -339 |
| Net Income | $-646 | $3,491 | $-705 | $-339 |
| EPS Basic Total Ops | -1.10 | 7.20 | -1.40 | -0.70 |
| EPS Basic Continuous Ops | -1.11 | 7.16 | -1.45 | -0.70 |
| EPS Diluted Total Ops | -1.10 | 7.20 | -1.40 | -0.70 |
| EPS Diluted Continuous Ops | -1.11 | 7.16 | -1.45 | -0.70 |
| EBITDA(a) | $297 | $5,030 | $23 | $9 |